(2022) Investigation of the relationship between miR-33a, miR-122, erythrocyte membrane fatty acids profile, and serum lipids with components of metabolic syndrome in type 2 diabetic patients. Research in Pharmaceutical Sciences. pp. 242-251. ISSN 17355362 (ISSN)
Full text not available from this repository.
Abstract
Background and purpose: MicroRNAs (miRNAs) are small non-coding RNA molecules acting as critical regulators of post-transcriptional gene expression. MiR-33a and miR-122 have a crucial role in cholesterol and lipid metabolism. Therefore, their dysregulation may contribute to metabolic abnormality and their inhibition may be a useful therapeutic strategy. The objective of the present study was to investigate the relationship between miR-33a, miR-122, erythrocyte membrane fatty acids profile, and serum lipids with components of metabolic syndrome in an Iranian population suffering from type 2 diabetes mellitus (T2DM). Experimental approach: Expression of miR-33a and miR-122 was measured by real-time polymerase chain reaction and erythrocyte membrane fatty acid profiles were analyzed by gas chromatography-mass spectrometry. Findings/Results: T2DM patients with and without metabolic syndrome had significantly higher miR-33a and miR-122 levels compared to controls. MiRNAs were significantly correlated with saturated fatty acid (SFAs), total SFAs/total polyunsaturated fatty acids (PUFAs) ratio, fasting plasma glucose, triacylglycerols, insulin and homeostatic model assessment of insulin resistance. In addition, there was a significant negative correlation between miR-33a and miR-122 levels and PUFAs, total PUFAs/total SFAs ratio and omega 6 fatty acids. Conclusion and implications: Considering the roles of miR-33a and miR-122 in cholesterol and lipids metabolism, it may be concluded that the measurement of their expression may be useful as a potential additional biomarker for cardiometabolic derangement in T2DM patients. In addition, these findings may suggest that the inhibition of these miRNAs by anti-miRNA therapies may be explored as a potential therapeutic strategy. © 2022 Wolters Kluwer Medknow Publications. All rights reserved.
Item Type: | Article |
---|---|
Keywords: | glucose insulin microRNA microRNA 122 microRNA 33a omega 6 fatty acid polyunsaturated fatty acid saturated fatty acid triacylglycerol unclassified drug adult Article biochemical analysis body height body weight controlled study cross-sectional study erythrocyte membrane fasting fatty acid analysis female gene expression gene expression level glucose blood level homeostasis model assessment human Iranian people lipid blood level lipid metabolism major clinical study male mass fragmentography metabolic syndrome X non insulin dependent diabetes mellitus real time polymerase chain reaction RNA isolation |
Page Range: | pp. 242-251 |
Journal or Publication Title: | Research in Pharmaceutical Sciences |
Journal Index: | Scopus |
Volume: | 17 |
Number: | 3 |
Identification Number: | https://doi.org/10.4103/1735-5362.343078 |
ISSN: | 17355362 (ISSN) |
Depositing User: | خانم ناهید ضیائی |
URI: | http://eprints.mui.ac.ir/id/eprint/25102 |
Actions (login required)
![]() |
View Item |